Class Action Lawsuit Announced Against Dentsply Sirona Inc. Amid Investor Concerns

Class Action Lawsuit Filed Against Dentsply Sirona Inc.



On January 10, 2025, the law firm Levi & Korsinsky, LLP announced its notification to investors regarding a significant class action securities lawsuit against Dentsply Sirona Inc., commonly referred to as Dentsply. This lawsuit is particularly relevant to investors who may have experienced financial losses due to alleged fraudulent practices carried out by the Company, specifically during the period spanning from May 6, 2021, to November 6, 2024.

Overview of the Allegations



The complaint filed in court details several counts of securities fraud linked to Dentsply's operations, particularly its sales strategies related to Byte, a direct-to-consumer aligner solution. Among the key allegations are that Dentsply inadequately targeted low-income individuals lacking access to proper dental care, which often led to patients with underlying dental issues qualifying for treatments they should not have received. This misalignment raises significant questions about both ethical practices and patient safety in the dental healthcare sector.

The lawsuit states that Dentsply’s urgent push for growth within Byte resulted in its sales team aggressively selling products to patients who did not meet the necessary criteria, thus failing to establish sufficient safeguards for appropriate patient onboarding. Many reports surfaced during this period concerning injuries associated with Byte aligners, yet the Company reportedly neglected these alarming trends, neither conducting proper investigations nor notifying the FDA in a timely manner as required by law.

Additionally, the complaint underscores that for years, Dentsply was aware of the serious injuries being reported by Byte patients but did little to amend its practices or alert regulatory authorities. This lack of responsiveness has not only undermined patient trust but also overstated the company's financial goodwill, particularly regarding its Byte investments.

Next Steps for Affected Investors



Investors who believe they have suffered losses due to these alleged misrepresentations are urged to act quickly. The deadline to request appointment as lead plaintiff in this case is January 27, 2025. It's crucial for potential claimants to note that participation in any recovery does not require lead plaintiff status.

Furthermore, it is essential to highlight that there is no fee or cost for class members who wish to participate in this lawsuit—meaning that any compensation received would be free of out-of-pocket costs.

Why Choose Levi & Korsinsky?



With two decades of experience in complex securities litigation, Levi & Korsinsky has established itself as a reputable firm, having secured hundreds of millions of dollars for distressed shareholders. The firm’s dedicated team is well-equipped to navigate the nuances of corporate fraud cases and has consistently ranked among the top securities litigation firms in the United States for several consecutive years.

Contact Information



For those interested in more information or wishing to participate in the lawsuit, Joseph E. Levi of Levi & Korsinsky can be contacted via email at [email protected] or by phone at (212) 363-7500. The firm is located at 33 Whitehall Street, 17th Floor, New York, NY 10004.

In conclusion, the unfolding events surrounding Dentsply Sirona Inc. provide a compelling case study of the urgent need for accountability and ethical responsibility in the healthcare industry. Investors are advised to remain vigilant and proactive in their advocacy for transparency and fairness in corporate practices.

Topics Financial Services & Investing)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.